UBS Raises Price Target on Zimmer Biomet Holdings (ZBH) Following 2Q Earnings Report
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Zimmer Biomet Holdings (ZBH): Accelerating Growth To Market Rates - Jefferies
August 2, 2016 7:26 AM EDTJefferies analyst, Raj Denhoy, reiterated his Buy rating on shares of Zimmer Biomet (NYSE: ZBH) after a review of 2Q growth rates for the ortho players shows that ZBH made tangible progress in closing the gap between the company's growth and the market. After adjusting for selling day differences, acquisitions, and currency, knees grew ~4.5% and hips... More
Jefferies Raises Price Target on Zimmer Biomet Holdings (ZBH) Following 2Q
July 29, 2016 7:51 AM EDTJefferies reiterated a Buy rating on Zimmer Biomet Holdings (NYSE: ZBH), and raised the price target to $150.00 (from $135.00), following the company's 2Q earnings report. GM was down 60bp, though OM was up 160bp as spending in SG&A was down 220bp. ZBH reported an... More
